Lands’ End (LE) announced that its Board has initiated a process to explore strategic alternatives, including a sale, merger or similar transaction involving the company,

Reuters reported that Riskified (RSKD), a provider of software that helps prevent e-commerce fraud, is exploring options including a potential sale after receiving takeover interest.

CarParts.com (PRTS) announced that it is engaged in a process to explore strategic alternatives to maximize shareholder value, including a possible sale of the company,

Bloomberg reported that Allegro Microsystems (ALGM) is drawing takeover interest from larger competitor On Semiconductor (ON). Phoenix-based Onsemi has been working with advisers in recent

Bo Yu Limited submitted a non-binding proposal to acquire all outstanding shares of OneConnect Financial Technology (OCFT) that it did not already own, in a

Select Equity, which holds 9.7% of Signet Jewelers (SIG), believes that the stock is undervalued and that the company could create more value for shareholders

Reuters reported that Cantaloupe (CTLP) is exploring strategic options, including a potential sale or a go-private transaction. The company is working with investment bankers at

LAVA Therapeutics (LVTX) has initiated a strategic review process aimed at maximizing shareholder value while implementing cost-cutting measures, including a workforce reduction. The company is

Chegg (CHGG) announced that it is launching a strategic review process and exploring a range of alternatives to maximize shareholder value, including being acquired, undertaking

The Financial Times reported that Nathan’s Famous (NATH), the iconic hot dog chain founded more than a century ago on New York’s Coney Island, is

Anterix (ATEX) announced that after receiving inbound interest in the company, it has engaged Morgan Stanley as its financial advisor to support a formal strategic

Reuters reported that Merck KGaA, the German healthcare and technology group, is in advanced talks to acquire U.S. cancer and rare diseases drugmaker Springworks Therapeutics